According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

In short, these results revealed that both CRLF2 OE and CRLF2-d are correlated with poor prognosis in ALL patients.

The CCL17/CCL22-CCR4 axis can be used as a novel biomarker for the prognosis of B-cell acute lymphoblastic leukemia (ALL), according to a new study published in the journal Cytokine. It is already ...

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or ...

Sep. 2, 2024 — Researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalized ...

The study did not provide details on the proportion of patients with therapy-related or secondary acute myeloid leukaemia, and on those with a poor or intermediate-risk karyotype. Complete remission ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor ...